Kevin F Mclaughlin, an insider of Aastrom Biosciences, just received 14,875 options and restricted shares from the company. The strike prices of the options received ranged from $0.00 to $16.62, and these expire on May 01, 2029. The restricted shares don't become available to Mclaughlin until such time as they become vested. Mclaughlin now has at least 13,125 options, and at least 1,750 restricted shares.
Some additional info was provided as follows:
The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.
Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first
Annual Meeting of Stockholders following May 1, 2019.
No expiration date for this type of award.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Aastrom Biosciences makes a similar move, sign up!
Other recent filings from the company include the following:
Aastrom: Vericel Announces Submission Of Biologics License Application To The Fda For Nexobrid For The Treatment Of Severe Thermal Burns - June 30, 2020
Aastrom Biosciences insider just cashed-in 14,751 options - June 24, 2020
Aastrom Biosciences insider just disposed of 1,112 shares - June 18, 2020
Brown Capital Management, LLC just provided an update on share ownership of Aastrom Biosciences - June 10, 2020